Search results for "Fever"

showing 10 items of 247 documents

A curious case of pancytopenia and fever in a patient with Erdheim–Chester disease

2022

NA

Settore MED/09 - Medicina InternaEmergency MedicineInternal Medicinepancytopenia fever Erdheim–Chester diseaseInternal and Emergency Medicine
researchProduct

Fever of Unknown Origin in Internal Medicine: A Reasonable Analysis of Causes and Mistakes

2013

Settore MED/09 - Medicina InternaInternal MedicineFever of Unknown Origin; Internal MedicineFever of Unknown Origin
researchProduct

Periodic fever: a case report.

2013

Settore MED/09 - Medicina InternaPeriodic fever
researchProduct

New diagnostic criteria of acute rheumatic fever: prevalence of silent carditis in a pediatric population

2017

Acute rheumatic fever and its sequel, chronic rheumatic heart disease, are important global health issues with an annual incidence of about 500.000 new cases and a prevalence of 34 million people worldwide affected by rheumatic heart disease. During the 20th century the incidence of ARF and the prevalence declined substantially in Europe, North America, and developed nations in other geographic locations. In Italy the incidence is about 4,1:100.000. Acute rheumatic fever is a systemic inflammatory response to group A streptococcal infection, which typically affects children and occurs two or three weeks after a throat infection. Although arthritis is the most common sign, carditis which com…

Settore MED/38 - Pediatria Generale E SpecialisticaAcute rheumatic fever rheumatic heart disease silent carditis
researchProduct

Adherence to colchicine treatment and colchicine resistance in a multicentric FMF national cohort

2020

Introduction: Colchicine is the standard treatment for Familiar Mediterranean Fever (FMF), however about 5% of patients (pts) experience colchicine resistance. There is no standard definition of colchicine resistance. Recently a panel of experts elaborated a new definition based on a Delphi consensus approach. Objectives: We aim to describe main features of the disease and clinical outcome of a cohort of FMF pts with particular interest on the colchicine resistance and tolerability according to the definitions proposed by the recent consensus.

Settore MED/38 - Pediatria Generale E SpecialisticaColchicine resistance Familiar Mediterranean Fever Delphi consensus approach
researchProduct

Platelet count and MPV as predictive markers of atherosclerosis in familial Mediterranean fever

2017

Familial Mediterranean Fever (FMF) is an auto inflammatory syndrome, characterized by recurrent febrile episodes, arthritis, oral aphthous stomatitis, rash, serositis, abdominal and thoracic pain. Longterm outcome is conventionally linked to the severity of the recurrent attacks and to the risk of systemic amyloidosis. However recent studies highlighted the role of chronic inflammatory diseases in the insurance of atherosclerosis. Risk factors for atherosclerosis are also recently identified in a higher medium platelet volume (MPV).

Settore MED/38 - Pediatria Generale E SpecialisticaFamilial Mediterranean Fever medium platelet volume atherosclerosis
researchProduct

Genetic and clinical profile of a paediatric population with FMF in Sicily

2017

Familial Mediterranean fever (FMF) is an Autoinflammatory syndrome that is common in children in Mediterranean countries. The real prevalence of FMF in Sicilian children is unknown and need a wide population study. Furthermore, there are no data on the real prevalence of the different mutations between FMF patients and the concordance and/or discordance in clinical and biochemical parameters between patients of different generations.

Settore MED/38 - Pediatria Generale E SpecialisticaFamilial Mediterranean fever Mediterranean countries
researchProduct

Perspective validation of the eurofever classification criteria for monogenic periodic fevers.

2014

We recently proposed a set of provisional, evidence-based, clinical criteria for the classification of children and adults patients affected by monogenic periodic fevers. These criteria, built and validated in a cohort of 1215 patients with periodic fever enrolled in the Eurofever Registry from November 2009 to February 2013, displayed a high sensitivity and specificity.

Settore MED/38 - Pediatria Generale E Specialisticaeurofever classification criteria monogenic periodic fevers
researchProduct

Sociodemographic Characteristics and Interests of FeverApp Users

2021

The FeverApp Registry is a model registry focusing on pediatric fever using a mobile app to collect data and present recommendations. The recorded interactions can clarify the relationship between user documentation and user information. This initial evaluation regarding features of participants and usage intensity of educational video, information library, and documentation of fever events covers the runtime of FeverApp for the first 14 months. Of the 1592 users, the educational opening video was viewed by 41.5%, the Info Library was viewed by 37.5%, and fever events were documented by 55.5%. In the current sample, the role of a mother (p &lt

Software documentation020205 medical informaticsHealth Toxicology and MutagenesisApplied psychologylcsh:Medicine02 engineering and technologyregistryArticleTask (project management)03 medical and health sciencesCurrent sample0302 clinical medicineDocumentation0202 electrical engineering electronic engineering information engineeringHumans030212 general & internal medicineRegistriesguidelinesChildFeverAppUser informationfeverData collectionbusiness.industrylcsh:RPublic Health Environmental and Occupational HealthMobile appsecological momentary assessmentuser behaviorUsabilityMobile Applicationsusabilitysociodemographic characteristicsbusinessPsychologyfeasibilityInternational Journal of Environmental Research and Public Health
researchProduct

CLINICAL FEATURES AND TREATMENT OF MEDITERRANEAN SPOTTED FEVER IN CHILDREN: A PRACTICAL UPDATE FOR THE CLINICIAN

2004

Mediterranean spotted fever (MSF) is a tick-borne disease caused by Rickettsia conorii. It is characterized by the symptomatologic triad of fever, exanthema and «tache noire» – the typical eschar at the site of the tick bite. Oral or parenteral administration of tetracyclines or chloramphenicol represent the standard treatment; however, both these drugs may cause significant adverse effects in children. Recent studies indicate that oral clarithromycin and azithromycin may represent an acceptable alternative for the treatment of children with MSF. There are no data to indicate that antimicrobial prophylaxis is beneficial for tick-bitten patients to prevent MSF. However, in the presence of a …

Spotted Fever Boutonneuse fever Rickettsia Clarithromycin Azithromycin
researchProduct